Search

Embecta Corp

Closed

SectorHealthcare

4.42 26.65

Overview

Share price change

24h

Current

Min

3.51

Max

4.68

Key metrics

By Trading Economics

Income

-48M

-4.1M

Sales

-39M

222M

P/E

Sector Avg

1.928

68.51

EPS

0.27

Dividend yield

16.48

Profit margin

-1.849

Employees

1,850

EBITDA

-51M

45M

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

-14.29% downside

Dividends

By Acuity

Dividend yield

Sector Avg

16.48%

2.29%

Next Earnings

7 Aug 2026

Next Dividend date

15 Sept 2026

Next Ex Dividend date

27 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-327M

221M

Previous open

-22.23

Previous close

4.42

News Sentiment

By Acuity

72%

28%

308 / 340 Healthcare

Embecta Corp Chart

Past performance is not a reliable indicator of future results.

Related News

6 Aug 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 Aug 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4 Aug 2026, 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3 Aug 2026, 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31 Jul 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30 Jul 2026, 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29 Jul 2026, 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28 Jul 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27 Jul 2026, 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24 Jul 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22 Jul 2026, 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21 Jul 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20 Jul 2026, 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Peer Comparison

Price change

Embecta Corp Forecast

Price Target

By TipRanks

-14.29% downside

12 Months Forecast

Average 3 USD  -14.29%

High 3 USD

Low 3 USD

Based on 2 Wall Street analysts offering 12 month price targets forEmbecta Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

2 ratings

0

Buy

1

Hold

1

Sell

Sentiment

By Acuity

308 / 340 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat